Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson's disease treatment
- PMID: 40851666
- PMCID: PMC12367693
- DOI: 10.3389/fnagi.2025.1640389
Acupuncture modulates the microbiota-gut-brain axis: a new strategy for Parkinson's disease treatment
Abstract
Parkinson's disease is a relatively common neurodegenerative disorder in clinical practice, and its prevalence is increasing worldwide. It not only causes patients to have movement disorders such as tremors and delayed initiation but also makes them suffer from olfactory disorders, gastrointestinal disorders, insomnia and other symptoms, which imposes a heavy burden on both patients and their families. In recent years, some scholars believe that the gut-brain axis may be the key to revealing the pathogenesis of Parkinson's disease. The changes in intestinal flora, or bacterial infections and oxidative stress, lead to abnormal aggregation of alpha-synuclein and formation of neurotoxic Lewy bodies, which are transmitted to the central nervous system via the vagus nerve, thus causing Parkinson's disease. A large number of evidence-based studies have shown that acupuncture is effective in treating motor disorders and non-motor symptoms such as constipation, neuropsychiatric symptoms, and dysphagia symptoms in Parkinson's disease, also this treatment is safe. However, its mechanism remains unclear. Acupuncture may affect the gut-brain axis and treat PD by improving intestinal flora imbalance, interfering with the expression of alpha-synuclein protecting neurological function, reducing imflammation, and influencing glial cells, etc. Therefore, the aim of this review is to elucidate the pathogenesis of PD from the perspective of neural, immune, and metabolic signaling pathways of the microbiota-gut-brain axis. In addition, this paper integrates the mechanism of acupuncture treatment with the pathogenesis of PD for the first time and to provide potential new strategies for its treatment.
Keywords: Parkinson’s disease; acupuncture; microbiota-gut-brain axis; pathogenesis; strategy.
Copyright © 2025 Zang, Yang, Qu, Ge, Tong, Xue, Sun and Hai.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
Short-chain fatty acids mediate enteric and central nervous system homeostasis in Parkinson's disease: Innovative therapies and their translation.Neural Regen Res. 2026 Mar 1;21(3):938-956. doi: 10.4103/NRR.NRR-D-24-01265. Epub 2025 Apr 29. Neural Regen Res. 2026. PMID: 40313087 Free PMC article.
-
Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation.J Parkinsons Dis. 2025 Jun;15(4):766-779. doi: 10.1177/1877718X251328567. Epub 2025 May 7. J Parkinsons Dis. 2025. PMID: 40336252
-
Exploring the role of gut microbiota in Parkinson's disease: insights from fecal microbiota transplantation.Front Neurosci. 2025 Jun 13;19:1574512. doi: 10.3389/fnins.2025.1574512. eCollection 2025. Front Neurosci. 2025. PMID: 40584885 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources